Jacobi Capital Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Jacobi Capital Management’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	-$1K	–	1304
2020 Q1	$1K	Hold	500	–	–	﹤0.01%	1120
2019 Q4	$1K	Hold	500	–	–	﹤0.01%	1055
2019 Q3	$1K	Hold	500	–	–	﹤0.01%	1034
2019 Q2	$2K	Hold	500	–	–	﹤0.01%	966
2019 Q1	$3K	Hold	500	–	–	﹤0.01%	872
2018 Q4	$3K	Hold	500	–	–	﹤0.01%	835
2018 Q3	$4K	Hold	500	–	–	﹤0.01%	837
2018 Q2	$6K	Buy	+500	New	+$6.85K	﹤0.01%	807

Jacobi Capital Management's NTGN Position: Q2 2020 in Review

Jacobi Capital Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 500 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in NTGN in Q2 2018 and held it in 8 quarters. The position peaked at $6K in Q2 2018. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Jacobi Capital Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Jacobi Capital Management sold 500 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $1K.
Jacobi Capital Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
Jacobi Capital Management's Neon Therapeutics, Inc. Common Stock position peaked at $6K in Q2 2018.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Jacobi Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.